O'Neill Frank J, Greenlee John E, Dörries Kristina, Clawson Susan A, Carney Helen
Department of Veterans Affairs, Salt Lake City Health Care System, Utah, USA.
J Neurovirol. 2003 Oct;9(5):567-76. doi: 10.1080/13550280390241223.
In immunologically normal individuals, the polyomavirus, JC virus (JCV), produces an asymptomatic primary infection followed by lifelong persistence of the virus in renal tubular epithelial cells. In some immunocompromised patients, however, in particular acquired immunodeficiency syndrome (AIDS) patients, JCV causes an opportunistic central nervous system (CNS) disorder, progressive multifocal leukoencephalopathy (PML). JCV DNA as it persists in kidneys (archetypal JCV) and JCV DNA isolated from PML lesions show differences in their regulatory regions in which transcription and replication are controlled. Archetypal JCV DNA has a single enhancer and no rearrangements or deletions in the regulatory region. In contrast, JCV DNA from PML isolates is characterized by alterations in the regulatory region. Some PML-associated JCVs can be grown in cultures of human fetal brain (HFB) cells. Growth of archetypal JCV in cultured cells has not been reported, however. Here we demonstrate successful propagation of the archetypal JCV, strain GS/K, in HFB cells. Growth occurred more slowly and to lower titers than is seen with the prototypical PML JCV strain Mad-1, with relatively few cells containing viral T antigen (T-Ag) or viral capsid protein, Vp1. Interestingly, GS/K growth could be enhanced, with a large increase in viral DNA and cytopathic effect, by coinfection with GS/B, a nonarchetypal brain-derived JCV variant isolated from the same PML patient as GS/K. The amount of GS/K DNA was also greatly enhanced when it was cotransfected with Mad-1 JCV DNA, the prototypical PML isolate. In contrast to GS/K plus GS/B-cotransfected cells, in GS/K plus Mad-1-infected cells, cytopathic effect was not increased. On subsequent passage of culture lysates to naïve cells, however, the infection produced by either combination of viral DNAs slowed, no cytopathic effect (CPE) was present, and the amount of GS/B or Mad-1 viral DNA was greatly reduced as compared to that of GS/K DNA. These data suggest that GS/K was able to use either GS/B or Mad-1 as a helper and that GS/K was in turn able to interfere with the growth of either helper virus. Archetype JCV can be successfully propagated in HFB cells, although infection develops much more slowly than that caused by the PML JCV variant Mad-1. The ability of archetypal and variant JCVs to enhance or retard each other's replication may have implications in vivo for the maintenance of JCV persistence and the growth of JCV variants.
在免疫功能正常的个体中,多瘤病毒JC病毒(JCV)会引发无症状的原发性感染,随后该病毒会在肾小管上皮细胞中持续终身。然而,在一些免疫功能低下的患者中,尤其是获得性免疫缺陷综合征(AIDS)患者,JCV会引发机会性中枢神经系统(CNS)疾病——进行性多灶性白质脑病(PML)。JCV DNA在肾脏中持续存在时(原型JCV),以及从PML病变中分离出的JCV DNA,在其调控区域存在差异,转录和复制在该区域受到控制。原型JCV DNA有一个单一的增强子,调控区域没有重排或缺失。相比之下,PML分离株中的JCV DNA的特征是调控区域发生改变。一些与PML相关的JCV可以在人胎脑(HFB)细胞培养物中生长。然而,尚未有关于原型JCV在培养细胞中生长的报道。在此,我们证明了原型JCV毒株GS/K在HFB细胞中成功增殖。其生长速度比典型的PML JCV毒株Mad-1更慢,滴度更低,含有病毒T抗原(T-Ag)或病毒衣壳蛋白Vp1的细胞相对较少。有趣的是,与GS/B共同感染可以增强GS/K的生长,使病毒DNA和细胞病变效应大幅增加,GS/B是从与GS/K相同的PML患者分离出的非原型脑源性JCV变体。当GS/K与原型PML分离株Mad-1 JCV DNA共转染时,GS/K DNA的量也会大幅增加。与GS/K加GS/B共转染的细胞不同,在GS/K加Mad-1感染的细胞中,细胞病变效应并未增加。然而,在随后将培养裂解物传代至未感染的细胞时,两种病毒DNA组合产生的感染速度减慢,不存在细胞病变效应(CPE),与GS/K DNA相比,GS/B或Mad-1病毒DNA的量大幅减少。这些数据表明,GS/K能够利用GS/B或Mad-1作为辅助病毒,并且GS/K反过来能够干扰这两种辅助病毒的生长。原型JCV可以在HFB细胞中成功增殖,尽管其感染发展速度比PML JCV变体Mad-1引起的感染慢得多。原型JCV和变体JCV相互增强或抑制彼此复制的能力可能在体内对JCV的持续存在和JCV变体的生长维持具有影响。